<DOC>
	<DOCNO>NCT01167335</DOCNO>
	<brief_summary>This study ass efficacy BGG492 adjunctive treatment patient refractory partial onset seizure</brief_summary>
	<brief_title>Evaluate Efficacy BGG492 Adjunctive Treatment Patients With Refractory Partial Onset Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<criteria>Outpatients ≥ 50 kg ( 110 lb ) weight A diagnosis epilepsy ( ≥ 2 year prior screen ) partial seizure without secondarily generalize seizure Uncontrolled partial seizure despite treat least two different AEDs within last 2 year prior screen . Treated stable dose 12 AEDs At least 4 partial seizure 4week baseline period least 4 partial seizure 4 week prior baseline period . No 28day seizurefree period 8 week precede randomization Positive biomarker screen Presence nonmotor simple partial seizure History psychogenic seizure Absences , myoclonic seizure e.g . context primary generalize epilepsy ; Previous history LennoxGastaut syndrome Pregnant nursing ( lactate ) woman Status epilepticus seizure cluster , accord judgement investigator , occur within 52 week prior randomization Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>partial onset seizure</keyword>
	<keyword>seizure frequency</keyword>
	<keyword>nervous system disease</keyword>
	<keyword>central nervous system disease</keyword>
	<keyword>CNS</keyword>
	<keyword>brain disease</keyword>
	<keyword>neurologic manifestation</keyword>
	<keyword>adjunctive treatment</keyword>
	<keyword>AEDs</keyword>
	<keyword>antiepileptic drug</keyword>
</DOC>